InfuSystem (INFU) Stock Price, News & Analysis

Company Overview

InfuSystem Holdings, Inc. is a provider of ambulatory infusion pump services and related healthcare solutions. The company supplies electronic infusion pumps and supports their use outside traditional hospital settings, helping patients receive prescribed therapies at home, in physician offices, and in other outpatient environments.

Its services include pump and equipment management, biomedical maintenance and repair, clinical support, patient education, supply and logistics services, and insurance and revenue-cycle support. InfuSystem primarily serves oncology and other specialty-care markets, including therapies involving pain management, immunoglobulin, and antibiotics.

InfuSystem serves healthcare providers and patients throughout the United States and Canada. The company is headquartered in Rochester Hills, Michigan. Richard DiLorio serves as its president and chief executive officer.

Key Stats

• Today's Range: $13.34 to $13.62
• 50-Day Range: $11.87 to $13.60
• 52-Week Range: $7.29 to $13.85
• Volume: 47,508 shs
• Average Volume: 159,630 shs
• Market Capitalization: $275.69 million
• P/E Ratio: 227.20
• Dividend Yield: N/A
• Price Target: $17.50
• Consensus Rating: Buy

InfuSystem Stock Analysis - MarketRank™

InfuSystem scored higher than 75% of companies evaluated by MarketBeat, and ranked 299th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

InfuSystem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

InfuSystem has a consensus price target of $17.50, representing about 29.9% upside from its current price of $13.47.

Amount of Analyst Coverage

InfuSystem has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 106.67%

Earnings Growth

Earnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of InfuSystem is 224.54, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.79.

Price to Earnings Ratio vs. Sector

The P/E ratio of InfuSystem is 224.54, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.44.

Price to Book Value per Share Ratio

InfuSystem has a P/B Ratio of 5.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for INFU.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

InfuSystem does not currently pay a dividend.

Dividend Growth

InfuSystem does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: N/A

News Sentiment

InfuSystem has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for InfuSystem this week, compared to 1 article on an average week.

Search Interest

4 people have searched for INFU on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

MarketBeat Follows

2 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, InfuSystem insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.80% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/07/2024
• Today: 10/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:INFU
• Previous Symbol: NYSE:INFU
• CIK: 1337013
• Web: www.infusystem.com
• Phone: (248) 291-1210
• Fax: 800-455-4338
• Employees: 473
• Year Founded: 2005

Price Target and Rating

• Average Price Target for InfuSystem: $17.50
• High Price Target: $20.00
• Low Price Target: $15.00
• Potential Upside/Downside: +28.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.41
• Trailing P/E Ratio: 227.20
• Forward P/E Ratio: 91.07
• P/E Growth: N/A
• Net Income: $870 thousand
• Net Margins: 1.12%
• Pretax Margin: 2.65%
• Return on Equity: 2.78%
• Return on Assets: 1.41%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 1.98
• Quick Ratio: 1.59

Sales & Book Value

• Annual Sales: $143.34 million
• Price / Sales: 1.92
• Cash Flow: $1.07 per share
• Price / Cash Flow: 12.79
• Book Value: $2.47 per share
• Price / Book: 5.53

Miscellaneous

• Outstanding Shares: 20,182,000
• Free Float: 19,095,000
• Market Cap: $275.69 million
• Optionable: Optionable
• Beta: 1.49